• Simple blood test
  • Full or critical exon coverage of 74 genes + MSI status from Circulating Tumour DNA (ctDNA)
  • Includes full range of genetic mutations:
    • single nucleotide variations (SNVs)
    • insertions/deletions (INDELs)
    • copy number alterations (CNAs)
    • fusions
    • microsatellite instability status (MSI)
  • Proprietary published targeted digital DNA sequencing method
  • Real time information (ctDNA 90 minute half life)
  • Published quality metrics:
    • robust assay with low failure rate (<1%)
    • high sensitivity across range of mutant allele
      fractions (MAF)
    • very high specificity
    • strong correlation with tissue biomarkers
    • Clinical response map with serial blood tests over time
    • Identifies FDA approved therapies and available clinical trials

Insurance cover


Please discuss with your
Insurance Provider
Tests covered by the PartnersLife Cancer Testing Benefit schedule

Our Partner

Enquire about a test

Testing is by referral from an Oncologist, medical or surgical specialist.
If you want more information, click on the button below.

Contact Us